Feedback / Questions
emilimogene sigulactibac topical (ILP-100 topical) - Ilya Pharma
https://news.cision.com/let-em-know-ab/r/ilya-pharma-receives-rare-pediatric-disease-designation-from-the-u-s--fda-for-emilimogene-sigulactib,c4036174#:~:text=em%20know%20AB%2F-,Ilya%20Pharma%20receives%20Rare%20Pediatric%20Disease%20Designation%20from%20the%20U.S.,skin%20wounds%20in%20SAVI%20patients
 
Sep 11, 2024
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious